Identity
- Security key
- 13482
- Ticker
- CLNN
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-12-31
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CLNN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $52,007,709.49
- Shares outstanding (class)
- 12,778,307
- Shares outstanding (weighted)
- 12,778,307
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 79
- Location
- SALT LAKE CITY, UT
- Homepage
- https://www.clene.com
- Description
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.